Plasmapheresis in Guillain-Barre syndrome

European Journal of Neurology

Volumn 3, Issue 5, 1996, Pages 417-423

  Korczyn, A D ^a   Nisipeanu, P ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Guilliain Barre syndrome; Plasmapheresis; Prognosis; Therapy

Indexed keywords

CAMPYLOBACTER JEJUNI; DISEASE COURSE; DISEASE SEVERITY; GASTROENTERITIS; GUILLAIN BARRE SYNDROME; HUMAN; MOBILIZATION; NERVE INJURY; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 0029805050     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1331.1996.tb00242.x     Document Type: Review

References (59)

1. Amason BGW and Soliven B (1993) Acute inflammatory demyelinating polyradiculoneuropathy. In: Peripheral Neurology (eds Dyck PJ and Thomas PK), 3rd edn, pp. 1437-1497. Philadelphia, Saunders.
2. Boucher CAB, de Gans J, van Oers R, Danner S and Goudsmit J (1988) Transmission of HIV and AIDS by plasmapheresis for Guillain-Barré syndrome. Clinical Neurology and Neurosurgery, 90, 235-236.
3. Brechenmacher C, Vital C and Deminiere C et al. (1987) Guillain-Barré syndrome: an ultrastructural study of peripheral nerve in 65 patients. Clinical Neuropathology, 6, 19-28.
4. Brettle RP, Gross M, Legg NJ, Lockwood M and Pallis C (1978). Treatment of acute polyneuropathy by plasma exchange. Lancet, 2, 1100.
5. Couriel D and Weinstein R (1994) Complications of therapeutic plasma exchange: a recent assessment. Journal of Clinical Apheresis, 9, 1-5.
6. Dutch Guillain-Barré Syndrome Group (1994) Treatment of Guillain- Barré Syndrome with high dose immunoglobulins combined with methylprednisone - a pilot study. Annals of Neurology, 35, 749-752.
7. Dyck PJ (1993) Is there an axonal variety of GBS? Neurology, 43, 1277-1280.
8. Dyck PJ and Kurtzke JF (1985) Plasmapheresis in Guillain-Barré syndrome. Neurology, 35, 1105-1107.
9. Dyck PJ, Daube J, O'Brien P, Pineda A, Low PA, Windebank A and Swanson C (1986) Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. New England Journal of Medicine, 314, 462-465.
10. Dyck PJ, Low PA and Windebank AJ et al (1991) Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. New England Journal of Medicine, 325, 1482-1486.
11. Färkkilä M, Kinnunen E, Haapanen E and Iivanainen M (1987) Guillain-Barré syndrome: quantitative measurement of plasma exchange therapy. Neurology, 37, 837-840.
12. French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome (1987) Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. Annals of Neurology, 22, 753-761.
13. French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome (1992) Plasma Exchange in Guillain-Barré syndrome: one-year follow-up. Annals of Neurology, 32, 94-97.
14. Geasby TE, Gilbert JJ, Brown WF, Bolton CF, Hahn AF, Koopman WF and Zochodne DW (1986) An acute axonal form of Guillain-Barré polyneuropathy. Brain, 109, 1115-1126.
15. Gibbels E and Giebisch U (1992) Natural course of acute and chronic monophasic inflammatory demyelinating polyneuropathies (IDP). A retrospective analysis of 266 cases. Acta Neurologica Scandinavica, 85, 282-291.
16. Goebel HH and Bohl JRE (1995) Neuropathology of the autonomic nervous system. In Handbook of Autonomic Nervous System Dysfunction (ed. Korczyn AD), pp. 41-52. New York, Marcel Dekker.
17. Gook JD, Tindall RAS, Walker J, Khan A and Rosenberg R (1980) Plasma exchange as a treatment of acute and chronic idiopathic autoimmune polyneuropathy: limited success. Neurology, 30, 361-362.
18. Greenwood RJ, Hughes RAC, Bowden AN, Gordon NS, Millac P, Newsom-Davis J, Asian S, Chadwick DW, McLellan DL, Stott RB and Armitage P (1984) Controlled trial of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet, 1, 877-879.
19. Gregson NA, Koblar S and Hughes RAC (1993) Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features. Quarterly Journal of Medicine, 86, 111-117.
20. Griffin JW, Wei-Hsiu and Ho T (1993) The Guillain-Barré syndrome at 75: the Campylobacter connection. Annals of Neurology, 34, 125-127.
21. Gruener G, Bosch EP, Strauss RG, Klugman M and Kimura J (1987) Prediction of early beneficial response to plasma exchange in Guillain-Barré syndrome. Archives of Neurology, 44, 295-298.
22. The Guillain-Barré Syndrome Study Group (1985) Plasmapheresis and acute Guillain-Barré syndrome. Neurology, 35, 1096-1104.
23. Guillain-Barré Syndrome Steroid Trial Group (1993) Double-blind trial of intravenous methylprednisolone in Guillain-Barré syndrome. Lancet, 341, 586-590.
24. Hartung HP, Pollard JD, Harvey GK and Toyka KV (1995a) Immunopathogenesis and treatment of the Guillain-Barré syndrome - Part I. Muscle and Nerve, 18, 137-53.
25. Hartung HP, Pollard JD, Harvey GK and Toyka KV (1995b) Immunopathogenesis and treatment of the Guillain-Barré syndrome - Part II. Muscle and Nerve, 18, 154-64.
26. Hughes RAC and Bihari D (1993) Acute neuromuscular respiratory paralysis. Journal of Neurology, Neurosurgery and Psychiatry, 56, 334-343.
27. Hughes RAC, Newsom-Davis JM, Perkin GD and Pierce JM (1978) Controlled trial of prednisolonc in acute polyneuropathy. Lancet, 2, 750-753.
28. Hughes R, Sanders E, Hall S, Atkinson P, Colchester A and Payan P (1992) Subacute idiopathic demyelinating polyradiculoneuropathy. Archives of Neurology, 49, 612-616.
29. Hughes RAC and Bihari D (1993) Acute neuromuscular respiratory paralysis. Journal of Neurology, Neurosurgery and Psychiatry, 56, 334-343.
30. Honavar M, Tharakan JK, Hughes RAC, Leibowitz S and Winer JB (1991) A clinicopathological study of the Guillain-Barré syndrome. Nine cases and literature review. Brain, 114, 1246-1269.
31. Jander S, Heidenreich F and Stoll G (1993) Serum and CSF levels of soluble intercellular adhesion molecule-1 (ICAM-1) in inflammatory neurologic diseases. Neurology, 43, 1809-13.
32. Kaldor J and Speed BR (1984) Guillain-Barré syndrome and Campylohacter jejuni: a serological study. British Medical Journal, 288, 1867-1870.
33. Kleyweg RP and van der Meché FG (1991) Treatment related fluctuations in Guillain-Barré syndrome after high dose immunoglobulins or plasma exchange. Journal of Neurology, Neurosurgery and Psychiatry, 54, 957-60.
34. Laskus T, Cianciara J and Slusarczyk J (1990) A follow-up study of an outbreak of non-A, non-B hepatitis in a plasmapheresis unit. Liver, 10, 49-53.
35. Maimone D, Annunjiata P, Simone IL, Livrea P and Guazyi GL (1993) Interleukin-6 levels in the cerebrospinal fluid and serum of patients with polyradiculoncuropathy. Journal of Neuroimmunology, 47, 55-61.
36. van der Meché FGA (1994) The Guillain-Barré syndrome: plasma exchange or immunoglobulins intravenously. Journal of Neurology, Neurosurgery and Psychiatry, 57, Suppl. 33-34.
37. van der Meché FGA, Schmitz PIM and The Dutch Guillain-Barré Study Group (1992) A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré Syndrome. New England Journal of Medicine, 326, 1123-1129.
38. McKhann GM, Griffin JW, Cornblath DR, Mellits ED, Fisher RS and Quaskey SA (1988) Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis. Annals of Neurology, 23, 347-353.
39. McKhann GM (1990) Guillain-Barré syndrome: clinical and therapeutic observations. Annals of Neurology, 27, Suppl, S13-S16.
40. Mendell JR, Kissel JT, Kennedy MS, Sahenk Z, Grinvalsky HT, Pittman GL, Kyler RS, Roelofs RI, Whitaker JN and Bertorini TE, (1985) Plasma exchange and prednisone in Guillain-Barré syndrome: a controlled randomized trial. Neurology, 35, 1551-1555.
41. Ng KK, Howard RS, Fish DR, Hirsh NP, Wiles CM, Murray NM and Miller DH (1995) Management and outcome of severe Guillain-Barré syndrome. Quarterly Journal of Medicine, 88, 243-250.
42. Osterman PO, Lundemo G, Pirskanen R, Fagius J, Pihlstedt P, Sidén Å and Säfwenberg J (1984) Beneficial effects of plasma exchange in acute inflammatory polyradiculoncuropathy. Lancet, 2, 1296-1298.
43. Palace JA and Hughes RAC (1994). Guillain-Barré syndrome with severe persistent disability: relationship to hyperacute Guillain-Barré syndrome. European Journal of Neurology, 1, 21-27.
44. Rees JH and Hughes RAC (1994) Campylobacter jejuni and Guillain-Barré Syndrome. Annals of Neurology, 35, 248-249.
45. Rees JH, Gregson NA, Griffiths PL and Hughes RAC (1993) Campylobacter jejuni and Guillain-Barré syndrome. Quarterly Journal of Medicine, 86, 623-634.
46. 1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Annals of Neurology, 38, 809-816.
47. Rees JH, Soudain SE, Gregson NA and Hughes RAC (1995b) Campylobacter jejuni infection and Guillain-Barré syndrome. New England Journal of Medicine, 333, 1374-9.
48. Ropper AH (1986) Severe acute Guillain-Barré syndrome. Neurology, 36, 429-432.
49. Ropper AH (1992) The Guillain-Barré syndrome. New England Journal of Medicine, 326, 1130-1136.
50. Ropper AH, Albers JW and Addison R (1988) Limited relapse in Guillain-Barré syndrome after plasma exchange. Archives of Neurology, 65, 314-15.
51. Sharief MK, McLean B and Thompson EJ (1993) Elevated serum levels of tumor necrosis factor-alpha in Guillain-Barré syndrome. Annals of Neurology, 33, 591-6.
52. 1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. Journal of Neurological Science, 114, 49-55.
53. Soffer D, Feldman S and Alter M (1978) Epidemiology of Guillain-Barré syndrome. Neurology, 28, 686-690.
54. Sutton DMC, Nair RC and Rock G, The Canadian Apheresis Group (1989) Complications of plasma exchange. Transfusion, 29, 124-127.
55. Therapeutic Plasmapheresis Consensus Development Conference (1986) The utility of therapeutic plasmapheresis for neurological disorders. JAMA, 256, 1333-1337.
56. Thomas PK (1992) The Guillain-Barré syndrome: no longer a simple concept. Neurology, 239, 361-362.
57. gG following plasma exchange (PE). Neurology, 44, Suppl. 2, A290.
58. Vriesendorp FJ, Mayer RF and Koski CL (1991) Kinetics of anti-peripheral nerve myelin antibody in patients with Guillain-Barré syndrome treated and not treated with plasmapheresis. Archives of Neurology, 48, 858-861.
59. 1 antibodies following Campylobacter enteritis. Neurology, 40, 1900-1902.